Biotecnología
Biotecnología
Peptone Expands Leadership Team with Key Executive Hires
29/09/2023 -
Patrik Foerch appointed chief scientific officer; David Lowe, senior vice president of protein therapeutics; and Benjamin Owens, chief business officer.
Ginkgo Bioworks, Pfizer Enter Multi-Target RNA Discovery Alliance
28/09/2023 -
Pfizer will leverage Ginkgo's RNA technology for the discovery and development of novel RNA molecules across priority research areas.
Chime, Panolos Partner to Advance Multi-specific Therapeutic Proteins
27/09/2023 -
Chime will provide development and manufacturing services to Panolos Bioscience for PB203.
Integrated DNA Technologies, Aldevron Partner on CRISPR Components
19/09/2023 -
Integrated DNA Technologies will sell Aldevron cGMP manufactured CRISPR nucleases.
GenScript Adds Circular RNA, Lipid Nanoparticles Formulation
19/09/2023 -
Aims to offer comprehensive range of RNA formats critical, enabling fast delivery of complex design for the R&D of RNA vaccines and therapeutics.
Curia Supports Replicate Bioscience’s Phase 1 Trial of RNA Vax
14/09/2023 -
Supply of drug substance manufactured under cGMP supports clinical study for RBI-4000 novel self-replicating RNA.
Eminence Opens GMP Cell Culture Media Manufacturing Facility
13/09/2023 -
Aims to address the rapidly growing demand for high-quality media in the fields of vaccines, gene, cell therapies, antibodies, and recombinant proteins.
Applied DNA Names Executive Director of Quality and cGMP Programs
13/09/2023 -
Beverly Wolgast will lead implementation of cGMP-quality LineaDNA Capability for IVT mRNA Production.
Colorcon Introduces TiO2-Free Moisture Protection Coating for Tablets
06/09/2023 -
Titanium dioxide free film coating designed to mitigate the challenges of moisture sensitive actives.
SomaLogic Expands Agreement with Novo Nordisk to 2025
06/09/2023 -
Novo Nordisk will extend its use of SomaLogic’s proteomics technologies in drug research and development.
Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus
01/09/2023 -
Investment enhances Almac’s NGS portfolio of DNA sequencing service offerings.
Pfizer’s ABRYSVO for Infant RSV Prevention Approved in Pregnant Women
28/08/2023 -
First and only U.S. approval of a maternal vaccine to help protect infants at birth through six months of life from lower respiratory tract disease.
Charles River, Fondazione Telethon Partner on Plasmid Manufacturing
28/08/2023 -
Charles River to manufacture HQ plasmid DNA for Fondazione Telethon’s lentivirus production.
Astex, Merck Expand Drug Discovery Alliance
10/08/2023 -
Aims to identify small molecule candidates with activity towards a tumor suppressor protein for the treatment of cancer.
Cáñamo: una economía regional sostenible en gran crecimiento
09/08/2023 -
Contenido
La Transformación Digital: el impulso para el crecimiento de las PyMEs de Alimentos.
Cáñamo: una economía regional sostenible en...
AAHI Receives $18M NIH Award to Develop Chikungunya RNA Vaccine
07/08/2023 -
To develop a temperature stable, single-dose vaccine candidate for the chikungunya virus using a live “attenuated” virus.
iTolerance, Northway Biotech Partner on Manufacture of Streptavidin-FasL Fusion Protein
03/08/2023 -
Supports advancement of iTolerance's development of iTOL-100 towards first in human clinical study for lead program, iTOL-102.
Oramed, HTIT Create Joint Venture to Advance Oral Drug Delivery
03/08/2023 -
Will focus on innovative products using Oramed's oral insulin and protein oral delivery and HTIT's manufacturing capabilities and technologies.
Ginkgo Bioworks Awarded $18M DARPA Contract
28/07/2023 -
Ginkgo aims to deliver advances in on-demand protein manufacturing leveraging Cell-Free Protein Synthesis.
Curia Expands Capabilities with Access to Touchlight’s Doggybone DNA
25/07/2023 -
Alliance expands Curia’s mRNA manufacturing offerings with an additional differentiated source of DNA raw material.
ABL Enters Seven-year Multimillion Dollar Contract with NIH
21/07/2023 -
Will support product development processes, documentation and production of customized recombinant proteins and monoclonal antibodies.
